share_log
  • Headlines
  • Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.

Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.

Benzinga ·  00:45
Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated